REVIEWED EXECUTIVE BRIEF / OCTOBER 2026
Disease Alert System: a proposed authorization-aware switchboard for agencies, healthcare and approved protective technologies.
Proposed concept. No operating federal system, endorsement or live integration represented.
01 / PURPOSE
Existing systems integrate biological intelligence, distribute cleared guidance and support authorized public warning. DAS proposes to connect a permitted event to role-specific tasks and track their completion. Potential recipients include clinicians, hospitals, laboratories, pharmacies, suppliers, insurance providers, emergency leaders, facility owners and approved community or transport partners. Insurer preparedness concerns claims-support capacity and coverage communications; the initial pilot excludes patient-level records. DTS would provide evaluated analytical support for potential geographic spread and readiness needs.
Nonpartisan public communication: DAS is proposed as a trusted, nonpartisan public communication system for disease-related safety information. Its purpose is public protection across communities, regardless of political affiliation. The proposed alert-content policy excludes campaign promotion, political fundraising and partisan advocacy.
The comparison to AMBER Alert is its public-safety purpose: timely, focused information that helps protect people. AMBER Alert helps find abducted children; DAS proposes disease-related safety communication. DAS is a separate proposal, with no AMBER Alert affiliation, government endorsement or existing public-warning authority represented. Trust must be earned through verified sources, designated approval, clear protective instructions, auditable decisions and timely corrections.
The testable hypothesis: one authorized incident can reach the right recipients and approved device workflows with fewer missed handoffs and a visible record of what happened. Benefits remain to be demonstrated.
02 / OPERATING MODEL
Trusted sources submit the minimum permitted incident metadata. Hospitals, laboratories, public-health authorities and enrolled sensors are potential sources, subject to agreements.
Check the source, permissions, timestamps, duplicate reports and data quality. A signal or model estimate is not a confirmed diagnosis.
Define the affected area, participating jurisdiction, recipient roles and escalation criteria. Restrict each route to authorized data and purpose.
Designated authorities review public messages and high-consequence actions. Preauthorized low-risk tasks may follow an agreed policy.
Clinicians receive cleared guidance; pharmacies receive readiness tasks; officials receive briefings. Public warnings use approved originators. Devices require separate safety gates.
Track delivery separately from acknowledgment and action completion. Surface failures, overrides and overdue tasks. Reassess and document closure.
03 / AGENCY PATHWAYS
NBIC already integrates and disseminates biological-threat information. The proposed DAS pilot would test what happens after a permitted event is shared.
Illustrative exercise: A signed, synthetic incident is scoped to approved operational roles; each role receives a task, due time and acknowledgment request.
Measure: Time to route; missed recipients; overdue tasks; authorized-action compliance.
CDC’s Health Alert Network distributes cleared urgent health information. DAS would support downstream routing and action tracking without creating clinical authority.
Illustrative exercise: Route a mock cleared advisory to clinicians, laboratories and pharmacies. Record receipt and requested readiness actions.
Measure: Acknowledgment time; recipient accuracy; guidance version consistency; task completion.
ASPR’s HPP supports healthcare preparedness and coalitions. DAS proposes a way to assign and track readiness tasks across participating facilities.
Illustrative exercise: A simulated surge prompts capacity checks, supply acknowledgments and escalation of unmet needs to the appropriate coordinator.
Measure: Facility response time; supply readiness; unmet-need resolution; escalation completion.
IPAWS supports messages from authorized alerting authorities. DAS would prepare and route information within agreed originator permissions.
Illustrative exercise: Use a sandbox message, limited geography and test recipients. Require approval; track cancellation, expiration and receipt.
Measure: Approval traceability; correct scope; message quality; blocked unauthorized releases.
Military health surveillance and command structures retain their responsibilities. Proposed DAS workflows would apply only within approved mission and owner boundaries.
Illustrative exercise: Use two installation roles and a synthetic overseas health advisory to test facility readiness and device-command permissions.
Measure: Readiness acknowledgment; dispatch time; command authorization; override success.
Local and national authorities lead investigation and response. Cross-border routing depends on agreements, applicable law and relevant official channels.
Illustrative exercise: Trace a verified waterborne event from local investigation through conditional international sharing to targeted U.S. readiness.
Measure: Appropriate escalation; minimal-data sharing; jurisdiction accuracy; local task completion.
04 / SCENARIOS
The supplied operational brief depicts a suspected plague exposure involving travel from Russia to Dallas/Fort Worth. Clinical and public-health verification precedes risk-specific readiness tasks. Any public warning requires an authorized originator and a justified risk. Minute-by-minute timings are scenario values, not measured capabilities. Pneumonic plague, rather than all forms of plague, is relevant to person-to-person respiratory-droplet transmission.
Local clinicians report a cluster. District and state authorities investigate cases and water sources; national coordination and relevant international reporting are conditional. U.S. readiness follows a credible domestic implication and authorized sharing, not automatic routing of every foreign outbreak to CDC or FEMA. Cholera is generally transmitted through contaminated food or water, not casual shared-air exposure.
05 / GOVERNANCE
Public health remains civilian-led. Public releases and high-consequence actions require designated approval. Device commands require enrollment, compatible interfaces, validated hazard-specific protocols, owner permission, expiry, acknowledgment and override. GermScan efficacy and compatibility are not independently established by the supplied records.
Begin with synthetic, minimum-necessary incident metadata and a device simulator. Do not include patient-level records, personal movement tracking or live warnings in the initial evaluation. Security, privacy, accessibility and applicable authorization requirements must be reviewed before an operational deployment.
The supplied Department of Disease Warfare seal is concept branding, not an official U.S. department seal. Legacy patent claims require a verifiable patent schedule. No independent outcome, savings, federal certification or live integration is established.
06 / EVALUATION & SCOPE
Phase 1: select the owner, use case, baseline and approval gates. Phase 2: connect signed synthetic events, mock recipients and a device simulator. Phase 3: run tabletop and technical exercises, including errors, cancellation and override.
Measure time to approved dispatch, correct recipient coverage, acknowledgments, task completion, blocked unsafe actions, reliability and usability. Agree on thresholds with the evaluation partner. Expansion is subject to review.
The subscription model is scoped by geography, population, integrations, support and readiness complexity. Source concept estimates are $150,000/month regional, $350,000/month multi-region, $900,000/month national and custom global scope. These are illustrative, unvalidated estimates, not an offer, government schedule or approved price.
Requested next step: a technical working session to define a bounded evaluation. Contact info@diseasealertsystem.com.
07 / REFERENCE BASE
